How many insider trades does FilingIQ track for ARTL?

FilingIQ tracks 39 Form 4 insider transactions for ARTL (ARTELO BIOSCIENCES, INC.), covering filings from Sep 4, 2019 onwards. 6 of those were filed in the last 90 days.

Are ARTL insiders net buyers or net sellers?

Across the full Form 4 history for ARTL, 12 transactions (31%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ARTL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ARTL in?

ARTELO BIOSCIENCES, INC. (ARTL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.57M.

ARTL insider trading

NasdaqCM Healthcare

ARTELO BIOSCIENCES, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

31% / 0%

Market cap

$3.57M

About ARTELO BIOSCIENCES, INC.

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Company website: artelobio.com

ARTL insider activity at a glance

FilingIQ has scored 39 insider transactions for ARTL since Sep 4, 2019. The most recent filing in our index is dated Jul 17, 2026.

Across the full history, 12 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ARTL insider trades is 67.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ARTL trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,047

UNITED THERAPEUTICS Corp

APLS 272

Apellis Pharmaceuticals, Inc.

NUVL 218

Nuvalent, Inc.

KYMR 203

Kymera Therapeutics, Inc.

HNGE 191

Hinge Health, Inc.

GH 189

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for ARTL?: FilingIQ tracks 39 Form 4 insider transactions for ARTL (ARTELO BIOSCIENCES, INC.), covering filings from Sep 4, 2019 onwards. 6 of those were filed in the last 90 days.
Are ARTL insiders net buyers or net sellers?: Across the full Form 4 history for ARTL, 12 transactions (31%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ARTL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ARTL in?: ARTELO BIOSCIENCES, INC. (ARTL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.57M.

Methodology & sources

Every ARTL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.